Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

盐酸二甲双胍缓释片 - NMPA Drug Approval Details

Approvals/NMPA/Metformin Hydrochloride Sustained-release Tablets

Approved

化学药品

Metformin Hydrochloride Sustained-release Tablets

广东三阶贸易有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 24, 2015
Approval ID: 7zyVE12996O
Company: 广东三阶贸易有限公司
Type: 化学药品

Approval Details

Approval Id: 7zyVE12996O
Approval Number: 国药准字H20051853
Generic Name: 盐酸二甲双胍缓释片
Generic Name En: Metformin Hydrochloride Sustained-release Tablets
Drug Type: 化学药品
Strength: 0.5g(以盐酸二甲双胍计)
Reg Date: 2015-09-24
Company Name: 广东三阶贸易有限公司
Production Company Address: 广州市白云区梅花园麦华路24号大院
Company Detail Path: /organization/yan-dong-san-jie-mao-yi-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 24, 2015

Approval ID

7zyVE12996O

Type

化学药品

Back to NMPA Approvals